Autorisation d’accès précoce refusée à la spécialité TEZSPIRE (Tézépélumab).
See also
Décision d'accès précoce
22/12/2022
eNrlWE1z2jAQvfMrGO7CfAbTMWRamrTMNFNKwrTTCyPkBUSF5OgDSH59ZUxa0rGbRkSX9MIISX67lt6+3XV0vluz8gakooL3KvVqrVIGTkRM+aJXmdxcorBy3i9FK7zBZcKwUr1KOq7OAHNV/Xb16T3Y3SAr/VI5ErMVEP1on9GUVT9itbzCSbqnHG0Ejctr0EsR9yqJ0fvZcqS0tDb7WyF/qAQTiILDzPHqato6no+CFOwfUI0C+QnzRS4ocCdMYqQErgdYw0LIu1zoRMb1aaMbntW7oZMRqsaghJEERlgvR1JsaAxxrq05ZgqcjMy38TXIDQOdGskFD1ZkrZzA8QrvxnA7zHf6rV0d6J1GNVTvdFuNs2bYbofNMydT8uio8uljXyJIps1mN2yFnQB4EAOhKfURb9QaDVRrdcIgJoGCNYoNqreR3QDrmQS0X7dzRDAGC7ALiGG0xEYDsj9CUr2fVJjbQSKktgMkYW7UYW8Ma8ztMEaYEFAokTZ0yAOSSqwrmKUoGu5VQiU4MmaU2maeuELV4DHvPdmRcPskJ2OqEobvqiuVuB4Vltgug7Tq5O9F0je4kVYvmT2zP/C5YSx4pteTg5p58jgVy4EwXBeI2uXY9SAGwsbGrvhG3XRY7w5cpKBeDvZe8PwcNDIzRomr0FopNKD0ZDws1tnXL1HvsIKJ9KdRXymPxVa9vPYdc82T9/t7YU+UE+22c2h/t8QuyMYXRooEAquKVJ0idkM+F6fKnI2VfKiHSHnlQbIvWQXBDAqKVuSowzY6Hmpsb/HnL7azhVzQDxc3rqT9YkDeXe//5kLTuPeLbm5JykfmsyFS6PjzAy7Tnb+2M3MybYSdVth0a2aMzJe1pdaJehME2+22usQqC73qXP4nyfCoKvLX4HkpvbJSNEsonlyfZZXC83jjKgNPFWenNhyH5w+NTa4NLQ2ccBdZxvCm68OLl08Vv7sNb26PHkmbPzP7zgBrq0++akMzyy8MT0pO9l75pbQC8Xk+pwVf3gp5GQXZV79+KQrSL3790k8mCrW5
bPW70YU6fGPHBefj